QuantSoar
HealthcareQuantSoar snapshot generatedΒ·Data source: Yahoo FinanceΒ·Market data may be delayed
A

A Stock Analysis

NYQ Β· Healthcare Β· Diagnostics & Research

$173.66

+0.87 (+0.50%)

A Interactive Price Chart & Trading Signals

A Stock Snapshot β€” Valuation, Risk & Technical Signals

A Key Fundamentals, Analyst Targets & Company Profile

Key Financial Ratios

Market Cap

$48.97B

P/E Ratio

34.32

Forward P/E

25.70

PEG Ratio

1.43

P/B Ratio

6.65

EPS

$5.06

Dividend Yield

0.59%

52W Range

$108.35 – $174.77

Beta

1.24

Volume

0.3M

ROE

21.0%

Profit Margin

19.5%

Revenue Growth

8.1%

Gross Margin

53.6%

EV/EBITDA

24.57

Analyst Target

$175.43

The trailing price-to-earnings ratio stands at 34.3x. Forward P/E of 25.7x implies earnings expansion expected. Price-to-book is 6.65x. EV/EBITDA sits at 24.57x. Market capitalization is $48.97B. Revenue is growing at 8.1% on a trailing basis. Earnings are expanding at 8.5%. Profit margins are 19.5%. Return on equity is 21.0%. Beta of 1.24 indicates elevated market sensitivity.

Analyst Consensus

Recommendation

Buy

Low Target

$155.00

Mean Target

$175.43

High Target

$190.00

Based on 21 analysts

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

United States18,200 employeesWebsite β†—

A Deep Dive Analysis

Bottom Line

Verdict

Overvalued

Best for

Higher-risk tolerance investors

Watch out for

Premium valuation, High volatility

Non-zero inputs

4/5

Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.

Agilent Technologies, Inc. (A) trades above our multi-model fair value estimate of $76.96 by approximately 55.7%. Trailing P/E: 34.3x. Profitability signals include profit margin of 19.5% and return on equity of 21.0%. Recent growth metrics show revenue growth of 8.1% and earnings growth of 8.5%. Risk profile: elevated market beta of 1.24. Consensus: buy.

Valuation, Growth & Risk

Valuation

Overvalued

P/E 34.3x

Price is above what fundamentals suggest.

Growth

Expanding

Rev 8.1%

Revenue is outpacing the market.

Risk

Elevated

Beta 1.24

Expect bigger swings than the market.

Valuation Snapshot

Agilent Technologies, Inc. (A) trades above our multi-model fair value estimate of $76.96 by approximately 55.7%. The trailing price-to-earnings ratio stands at 34.3x. Forward P/E of 25.7x suggests earnings compression ahead. Price-to-sales is 6.6x. Price-to-book is 6.7x. EV/EBITDA sits at 24.6x. Market capitalization is $48.97B.

Why it matters: Paying a premium works only if the company keeps growing faster than expected.

Growth & Profitability

Revenue is growing at 8.1% on a trailing basis. Earnings are expanding at 8.5%. Profit margins are 19.5%. Return on equity is 21.0%. Return on assets is 8.6%.

Why it matters: Growing revenue with healthy margins usually means the business is gaining market share or pricing power.

Risk Profile

Beta of 1.24 indicates elevated market sensitivity. Net debt position is $2.39B.

Why it matters: A riskier stock can fall more in a downturn. Make sure your portfolio can handle the volatility.

Analyst Context

Analyst consensus target of $175.43 implies 1.0% upside. Target range spans $155.00 to $190.00. 21 analysts cover the stock. Consensus recommendation: buy.

Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.

Data Methodology & Sources

Market Data (Facts)

  • Price, volume, and market cap: Yahoo Finance (may be delayed)
  • P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
  • Analyst estimates: Yahoo Finance (coverage and update times vary)
  • Insider transactions: Yahoo Finance (reporting may be delayed)

QuantSoar Model (Derived)

  • Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
  • Margin of Safety = (Fair Value βˆ’ Displayed Price) / Displayed Price Γ— 100
  • Composite Score: 40% Value + 30% Momentum + 30% Risk
  • Verdict Gauge: Base 50 + Valuation (up to Β±25) + Whale sentiment (up to Β±10) + Insider buying (+5) + Macro risk (up to Β±10) + Technical signal (up to Β±10). Analyst consensus is separate.

Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.

A Overvalued

Agilent Technologies, Inc. (A) trades above our multi-model fair value estimate of $76.96 by approximately 55.7%.

Frequently Asked Questions

ValuationIs A stock overvalued right now?
Based on our discounted cash flow and relative valuation models, A appears to trade above fair value by approximately 55.7%. This suggests the market may be pricing in elevated growth expectations or sentiment premiums.
ValuationWhat is A fair value based on current fundamentals?
Our fair value estimate for A is $76.96, derived from discounted cash flow, dividend discount, and relative valuation multiples. The estimate assumes a discount rate of 9.0% and terminal growth of 2.5%.
RiskHow risky is A compared with other stocks?
Risk profile for A: a beta of 1.24 indicates above-average market sensitivity. Investors should weigh macro exposure against their own risk tolerance.
GrowthIs A still growing?
Latest trailing metrics show revenue growth of 8.1% and earnings growth of 8.5%. Profit margins are 19.5%.
AnalystWhat do analysts think about A?
Analyst consensus target is $175.43, implying 1.0% upside. The street recommendation is "buy".
DividendDoes A pay a dividend?
Yes. A currently offers a dividend yield of 0.6%.
CatalystWhat could change the investment case for A?
Key catalysts include Healthcare sector dynamics, interest rate shifts, and company-specific earnings surprises. Monitor macro risk scores and analyst estimate revisions for early signals.

Related Stocks

Phasakorn Traklang (Peach)

About the Author

Phasakorn Traklang (Peach) β€” Founder

Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.

Connect on LinkedIn

Investment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC

Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.